6-Hour Virtual Seminar

6-Hour Virtual Seminar on GCP/GLP/GMP: Comparison and Understanding of the FDA's 3 Major Regulations

Product Id : 12808
John E Lincoln

Price Details

$545.00 Live
$745.00 Corporate Live
$595.00 Recorded
$945.00 Corporate Recorded
Combo Offers
Live + Recorded
$912.00   $1140.   (20% Off)
Corporate (Live + Recorded)
$1,352.00   $1690.   (20% Off)

Refund Policy

Price Details  +

The Good Laboratory Practice regulations describe the minimal standards for conducting nonclinical laboratory studies that support or are intended to support applications for research or marketing permits for products regulated by FDA or EPA such as animal food additives, human and animal drugs, medical devices for human use, biological products, electronic products, or pesticide products. The Good Clinical Practices regulations pertain to studies utilizing human subjects or clinical studies. While the GLPs do not specifically pertain to basic exploratory studies carried out to determine whether a test article has any potential utility or, for FDA studies only, to determine physical or chemical characteristics of a test article, adherence to their principles will further ensure the accuracy of any results achieved. And the GMPs pertain to the manufacture of product to be used in trials and then in release to the field / public.

Why you should attend

This Seminar will define what are the US FDA's expectation for proper laboratory / clinical / manufacturing practices, systems, equipment usage, and documentation / record-keeping. It will evaluate the requirements for how basic Quality Management System (QMS) expectations / requirements are addressed in these environment. The Seminar with evaluate pharma GMPs and 21 CFR 58 and associated regulations to see how the GLP's can be implemented in the real world to achieve FDA requirements and ensure the accuracy and repeatability / reproducibility of lab results. There will be a detailed analysis of the applicalble regulations for industry. Subject areas considered are:

  • Lab / Clinical / Manufacturing Control / Systems
  • Facilities and Equipment
  • Documentation and Records
  • Materials Management
  • Personnel / Assignments
  • Validation
  • The Lab GLPs, IRBs/GCPs, and company CGMPs

Who Will Benefit

  • Senior Management in Devices, Pharma, Combination Products
  • QA / RA
  • Medical Products Development and Testing testing Teams
  • R&D
  • Engineering
  • Production
  • Operations
  • Marketing
  • Consultants; others tasked with Medical Product Development, Manufacturing, Logistics  and V&V Responsibilities

  • Key Regulatory Expectations
  • GLP/ GCP / GMP specifics 
  • Systems, Personnel, Facilities 
  • Required documentation / records
  • Control of equipment / test  material / samples 
  • Laboratory Controls in the CGMPs
  • Clinical documents
  • CGMP requirements
  • Validations

Speaker Profile
John E. Lincoln is a medical device and regulatory affairs consultant. He has helped companies to implement or modify their GMP systems and procedures, product risk management, U.S. FDA responses. In addition, he has successfully designed, written and run all types of process, equipment and software qualifications/validations, which have passed FDA audit or submission scrutiny, and described in peer-reviewed technical articles, and workshops, world wide. John has also managed pilot production, regulatory affairs, product development/design control, 510(k) submissions, risk management per ISO 14971, and projects; with over 28 years of experience in the FDA-regulated medical products industry - working with start-ups to Fortune 100 companies, including Abbott Laboratories, Hospira, Tyco/Mallinckrodt. He is a graduate of UCLA.

Sign Up for Our Newsletter